Nuzenio

Praxis Precision Medicines

Praxis Precision Medicines news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 22 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Is Praxis (PRAX) Trading Bigger Losses for Long-Run CNS Ambition With Its Cash War Chest? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 22:12:08 GMT A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $462 to $800 - MoomooMoomoo · Sat, 08 Aug 2026 05:28:15 GMT RBC Adjusts PT on Praxis Precision Medicines to $462 From $449, Keeps Outperform Speculative Risk Rating - MoomooMoomoo · Fri, 07 Aug 2026 14:51:45 GMT Praxis Precision Medicines, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 12:30:00 GMT Praxis Precision Medicines Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 08:04:00 GMT Wedbush Adjusts PT on Praxis Precision Medicines to $188 From $162, Maintains Underperform Rating - MoomooMoomoo · Fri, 07 Aug 2026 04:47:24 GMT Praxis Precision Medicines, Inc. Stock 12‑Month Price Target Raised to $620.95, Implies 95% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:28 GMT Praxis Precision Medicines Inc (PRAX) (Q2 2026) Earnings Call Highlights: FDA Approvals on ... - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 23:15:13 GMT

Timeline

Sat, 08 Aug 2026 22:12:08 GMTIs Praxis (PRAX) Trading Bigger Losses for Long-Run CNS Ambition With Its Cash War Chest? - Yahoo Finance

Sat, 08 Aug 2026 05:28:15 GMTA Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $462 to $800 - Moomoo

Fri, 07 Aug 2026 14:51:45 GMTRBC Adjusts PT on Praxis Precision Medicines to $462 From $449, Keeps Outperform Speculative Risk Rating - Moomoo

Fri, 07 Aug 2026 12:30:00 GMTPraxis Precision Medicines, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Fri, 07 Aug 2026 08:04:00 GMTPraxis Precision Medicines Q2 Earnings Call Highlights - TradingView

Fri, 07 Aug 2026 04:47:24 GMTWedbush Adjusts PT on Praxis Precision Medicines to $188 From $162, Maintains Underperform Rating - Moomoo

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

PRAX10 live mentions Inc9 live mentions Medicines8 live mentions From4 live mentions Earnings Call Highlights4 live mentions TradingView Praxis Precision4 live mentions INC4 live mentions PRICE TO4 live mentions FROM4 live mentions CNS4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Praxis Precision Medicines.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.